WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

60.2x

EV/EBITDA

13.0x

Market Cap

JPY 10.62B

MomentumView details →

1D Return

−0.97%

YTD Return

+6.99%

RSI (14)

64.5

ValuationView details →

P/E (Fwd)

60.2x

EV/EBITDA

13.0x

Market Cap

JPY 10.62B

RSI (14)

64.5

MomentumView details →

1D Return

−0.97%

YTD Return

+6.99%

ProfitabilityView details →

Gross Margin

38.98%

Net Margin

3.21%

EBITDA Margin

−0.29%

ROE (TTM)

2.46%

ROA (TTM)

1.88%

Asset Turnover

0.61x

GrowthView details →

Revenue YoY

+16.78%

EPS YoY

+1.36%

FCF YoY

—

Revenue CAGR 3Y

−2.42%

EPS CAGR 3Y

−35.42%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

4.00x

Quick Ratio

3.03x

Div Yield

0.98%

Div Rate

—

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

9.29B

Net Income (TTM)

298.00M

Op. CF (TTM)

—

Next earningsNov 9, 2026 →

Latest newsMore news →

Asset Value Investors, a London-based investment adviser, increased its shareholding in Wakamoto Pharmaceutical from 10.60% to 11.64%, as disclosed in a change report filed with the Kanto Finance Bureau on August 27, 2026.8d ago

Similar companies

Immuno-Biological Laboratories Co.,Ltd.4570.T MediciNova,Inc.4875.T KAINOS Laboratories,Inc.4556.T K Pharma,Inc.4896.T STELLA PHARMA CORPORATION4888.T MORISHITA JINTAN CO.,LTD.4524.T Find similar companies →

Latest newsMore news →

Asset Value Investors, a London-based investment adviser, increased its shareholding in Wakamoto Pharmaceutical from 10.60% to 11.64%, as disclosed in a change report filed with the Kanto Finance Bureau on August 27, 2026.8d ago